concept

MYELINATION

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about MYELINATION: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

592Connections

7Hypotheses

2Analyses

50Outgoing

50Incoming

0Experiments

2Debates

Summary

MYELINATION is a concept in neurodegeneration research. Key relationships include: co discussed, impairs, expressed in. Associated with ALZHEIMER, ALZHEIMER'S, ALZHEIMER'S DISEASE. Connected to 57 entities in the SciDEX knowledge graph.

View on Wiki →

No AI portrait yet

💡 Concept Info

Name	MYELINATION
Key Genes/Proteins	APOE4

Wiki Pages (1)

Knowledge base pages for this entity

Canonical Page

Oligodendrocytes in CNS Myelination

cell · 1109 words

→

Pathway Diagram

graph TD
    MYELINATION["MYELINATION"]
    HDAC7["HDAC7"] -->|"regulates"| MYELINATION
    AQP4["AQP4"] -->|"activates"| MYELINATION
    CD19["CD19"] -->|"target for"| MYELINATION
    GPR37["GPR37"] -->|"inhibits"| MYELINATION
    CR2["CR2"] -->|"inhibits"| MYELINATION
    OVERVIEW["OVERVIEW"] -->|"inhibits"| MYELINATION
    SOD1["SOD1"] -->|"regulates"| MYELINATION
    GFAP["GFAP"] -->|"activates"| MYELINATION
    COMPLEMENT["COMPLEMENT"] -->|"causes"| MYELINATION

Outgoing (96)

Target	Relation	Type	Str
RNA	regulates	gene	0.60
SREBF2	regulates	gene	0.60
OLIGODENDROCYTES	co_discussed	entity	0.50
STING	co_discussed	entity	0.50
REMYELINATION	co_discussed	entity	0.50
NEURODEGENERATION	co_discussed	entity	0.50
OPTN	co_discussed	entity	0.50
RIPK1	co_discussed	entity	0.50
RIPK3	co_discussed	entity	0.50
NEURONS	co_discussed	cell_type	0.50
NEURON	co_discussed	cell_type	0.50
MYELIN	inhibits	concept	0.50
MYELIN	associated_with	concept	0.50
REMYELINATION	associated_with	concept	0.50
MYELIN	interacts_with	concept	0.50
MYELIN	regulates	concept	0.50
disease	expressed_in	disease	0.50
NEURONS	expressed_in	concept	0.50
PARKINSON'S	expressed_in	concept	0.50
OLIGODENDROCYTES	expressed_in	concept	0.50
DEMYELINATION	expressed_in	concept	0.50
OLIGODENDROCYTES	associated_with	concept	0.50
CENTRAL NERVOUS SYSTEM	associated_with	concept	0.50
CELL PROLIFERATION	regulates	concept	0.50
Cognitive Impairment	inhibits	phenotype	0.50
MYELIN	activates	concept	0.50
White Matter	activates	process	0.50
REMYELINATION	activates	concept	0.50
Cortex	inhibits	brain_region	0.50
AXON	inhibits	concept	0.50
Proteins	inhibits	protein	0.50
AXON	regulates	concept	0.50
MTOR SIGNALING	regulates	concept	0.50
AXON	associated_with	concept	0.50
AXON	activates	concept	0.50
VESICLE TRAFFICKING	activates	concept	0.50
Proteins	associated_with	protein	0.50
MYELIN	causes	concept	0.50
OLIGODENDROCYTES	causes	concept	0.50
MYELIN	expressed_in	concept	0.50
GENE EXPRESSION	regulates	concept	0.50
MYELIN	protects_against	concept	0.50
DEMYELINATION	protects_against	concept	0.50
Spinal Cord	activates	cell_type	0.50
OLIGODENDROCYTES	activates	concept	0.50
disease	inhibits	disease	0.50
White Matter	inhibits	process	0.50
NEURODEGENERATIVE DISEASE	inhibits	concept	0.50
Spinal Cord	inhibits	cell_type	0.50
OLIGODENDROCYTES	regulates	concept	0.50

Incoming (496)

Source	Relation	Type	Str
APOE4	associated_with	gene	0.95
Iron	involved_in	compound	0.95
OCN	inhibits	protein	0.95
APOE4	impairs	gene	0.90
APOE4	impairs	gene	0.90
Cholesterol Dysregulation	inhibits	mechanism	0.90
Microglia Activation	regulates	process	0.85
Microglia	regulates	cell_type	0.80
GBA1	regulates	gene	0.80
HDAC7	regulates	protein	0.80
BACE1	regulates	gene	0.70
ABCA1/ABCG1	therapeutic_target_for	gene	0.70
MICROGLIA	activates	gene	0.60
ANXIETY	activates	gene	0.60
ALZHEIMER	activates	gene	0.60
ASTROCYTE	associated_with	gene	0.60
DISEASE-ASSOCIATED MICROGLIA	associated_with	gene	0.60
ALZHEIMER'S DISEASE	activates	gene	0.60
PARKINSON'S DISEASE	activates	gene	0.60
MYELIN	inhibits	gene	0.60
CD19	therapeutic_target	gene	0.60
OLIGODENDROCYTE	inhibits	gene	0.60
INFLAMMATION	activates	gene	0.60
CYTOKINES	activates	gene	0.60
JUN	associated_with	gene	0.60
MICROGLIA	associated_with	gene	0.60
CR2	inhibits	gene	0.60
GPR37	inhibits	gene	0.60
GUT-BRAIN AXIS	activates	gene	0.60
OVERVIEW	inhibits	gene	0.60
EPILEPSY	causes	gene	0.60
ASTROCYTE	causes	gene	0.60
GABRG2	causes	gene	0.60
PHAGOCYTOSIS	activates	gene	0.60
RIPK3	associated_with	gene	0.60
RIPK1	associated_with	gene	0.60
C4B	associated_with	gene	0.60
OPTN	associated_with	gene	0.60
SOD1	regulates	gene	0.60
TREM2	associated_with	gene	0.60
GABRG2	associated_with	gene	0.60
NEUROINFLAMMATION	causes	gene	0.60
TNF	associated_with	gene	0.60
VEGF	associated_with	gene	0.60
GABRA1	causes	gene	0.60
GENES	causes	gene	0.60
ST3GAL5	contributes_to	gene	0.60
BANG	activates	gene	0.60
CANCER	associated_with	gene	0.60
MLKL	associated_with	gene	0.60

Targeting Hypotheses (7)

Hypotheses where this entity is a therapeutic target

Hypothesis	Score	Disease	Analysis
OPC exhaustion and failed remyelination in progressive multi	0.670	neurodegeneration	Test
Oligodendrocyte Remyelination Enhancement	0.644	neurodegeneration	Gene expression changes in aging mouse b
MOG-IgG induces spinal cord demyelination through Fcγ recept	0.560	neuroinflammation	What are the specific pathophysiological
BMP4 Pathway Inhibition for Oligodendrocyte Myelination Supp	0.536	neurodegeneration	Cell type vulnerability in Alzheimer's D
Oligodendrocyte Lineage Vulnerability: Early Myelination Dis	0.530	neurodegeneration	Cell type vulnerability debate in Alzhei

TREM2-Mediated Microglial Regulation of Oligodendrocyte Prec	0.380	connectomics	Human connectome alterations in Alzheime
Oligodendrocyte Precursor Cell Activation for Remyelination	0.000	-	Cell type vulnerability in Alzheimers Di

Mentioning Analyses (2)

Scientific analyses that reference this entity

What are the physiological functions of BACE1 beyond APP processing that could c

neurodegeneration | 2026-04-15 | 1 hypotheses Top: 0.743

What specific molecular mechanisms link APOE4 to cholesterol dysregulation in ol

neurodegeneration | 2026-04-14 | 1 hypotheses Top: 0.721

Experiments (0)

Experimental studies targeting or related to this entity

Experiment	Type	Disease	Score	Feasibility	Model	Status	Est. Cost
No experiments found

Related Papers (15)

Scientific publications cited in analyses involving this entity

Title & PMID	Authors	Journal	Year
cGAMP Enhances Microglial/Macrophage Phagocytosis in Ischemic Stroke Via Activat [PMID:41495583]	["Li Xinyu", "Ding Huamin", "Qian Shuyu"	Inflammation	2026
The gain-of-function TREM2-T96K mutation increases risk for Alzheimer's disease [PMID:41109213]	Pilat DJ, Le H, Prokopenko D, Lin CJ, Ei	Neuron	2026
Role of TREM2 in neuroinflammation. [PMID:41213496]	Abdulkhaliq AA, Alasiri G, Almoghrabi Y,	Exp Neurol	2026
Fusion of Tumor Cells with Lipid-Associated Macrophages Drives Metastatic Progre [PMID:41342370]	Cheng Y, Huang G, Liu X, Wu C, Lian J et	Cancer Res	2026
ANGPTL4 regulates the adipogenic-osteogenic differentiation balance of bone marr [PMID:41482017]	Huang F, Zhu Z, Xing Q, Li M	Biochimie	2026
Targeting senescent EGR1(+) B cells enhances immunotherapy efficacy in esophagea [PMID:41483805]	Zhou P, Zhang Y, Zhang H, Zhao P, Guo Y	Cell Rep Med	2026
Synergistic potential of TREM2 agonists and exercise training in Alzheimer's dis [PMID:41494649]	Zhang J, St Pierre Schneider B, Muguerza	Am J Physiol Endocrinol Metab	2026
Peripheral cancer attenuates amyloid pathology in Alzheimer's disease via cystat [PMID:41576952]	Li X, Tang X, Zeng J, Duan L, Hou Z et a	Cell	2026
TREM2 expression level is critical for microglial state, metabolic capacity and [PMID:41580393]	Feiten AF, Dahm K, Schlepckow K, van Len	Nat Commun	2026
TREM2 and microglial immunity in Alzheimer's disease: mechanisms, genetics, and [PMID:41789102]	Wang T, Liu X, Wang X, Hua F, Yan L	Front Immunol	2026
TREM2 in neurodegeneration and diseases. [PMID:41792456]	["Abdulkhaliq A", "Alasiri G", "Kim B",	Molecular psychiatry	2026
Alzheimer's Disease as a Disorder of Neuroimmune Dysregulation. [PMID:41745721]	Aranda-Abreu GE, Rojas-Durán F, Hernánde	Neurology international	2026
Molecular mechanism of Alzheimer's disease using integrated multi-omics. [PMID:41907842]	Alhusaini M, Mussa BM, Ilce BY, Alhaj H,	Frontiers in aging neuroscienc	2026
Viral and non-viral cellular therapies for neurodegeneration. [PMID:41585268]	["Srivastav Jyotsna", "Sharma Sachin"]	Frontiers in medicine	2025
BMP4 dose dictates lineage specification bias in human periodontal ligament stem [PMID:41568233]	Li Y, Tang Q, Li L, Lin C, Guo M et al.	Front Bioeng Biotechnol	2025

Debates (2)

Multi-agent debates referencing this entity

The abstract identifies APOE4's primary effect on oligodendrocyte cholesterol me

closed · Rounds: 4 · Score: 0.69 · 2026-04-16

The abstract identifies BACE1 as an attractive drug target but doesn't address i

closed · Rounds: 4 · Score: 0.76 · 2026-04-16

Related Research

Hypotheses and analyses mentioning MYELINATION in their description or question text

TREM2-Mediated Microglial Regulation of Oligodendrocyte Precursor Cell Recruitme

Score: 0.380 · connectomics · 2026-04-27

This hypothesis proposes that activated microglia use TREM2 signaling to coordinate both synaptic pruning and oligodendr

Oligodendrocyte Precursor Cell Activation for Remyelination

Score: 0.000 · unknown disease · 2026-04-28

Pharmacological activation of quiescent OPCs through combined PDGFR-α agonism using clemastine analogs with enhanced CNS